SCHEDULE 13D

Company

Lineage Cell Therapeutics, Inc.

Filed

January 11, 2006

Accession Number

0000950134-06-000388

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →